Earnings Call · Q1 FY2021·2021-05-11

Q1 21EPS -7.69%·Rev n/aQ4 20EPS +15.00%·Rev n/aQ3 20EPS -47.06%·Rev n/aQ2 20EPS +97.55%·Rev n/a⚠ consensus missing

Xenon Pharmaceuticals Inc. XENE

Jodi Regts — Investor Relations

Ian Mortimer — President and Chief Financial Officer

Simon Pimstone — Chief Executive Officer

Sherry Aulin — Chief Financial Officer

−2.8%1d on move date3d−3.3%5d+0.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more XENE calls or request research access.

More XENE calls Browse calls Request research access